181 filings
6-K
NBTX
Nanobiotix
24 Apr 24
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
4:49pm
20-F
2023 FY
NBTX
Nanobiotix
Annual report (foreign)
24 Apr 24
4:23pm
6-K
NBTX
Nanobiotix
17 Apr 24
Current report (foreign)
4:15pm
6-K
NBTX
Nanobiotix
10 Apr 24
Voting Rights and Shares Capital of the Company
4:15pm
6-K
NBTX
Nanobiotix
2 Apr 24
Current report (foreign)
4:15pm
6-K
k7egsaj5hkmfs0a ygtj
6 Mar 24
Nanobiotix to Present at Upcoming Investor Conferences in March
4:15pm
6-K
su7rptcn99rmi
13 Feb 24
Voting Rights and Shares Capital of the Company
4:15pm
6-K
vmmb75 hq7w
31 Jan 24
Nanobiotix to Present at the Guggenheim 6th Annual Biotechnology Conference
4:15pm
6-K
sa60q0
29 Jan 24
Nanobiotix Announces Achievement of $20M Development Milestone Payment Related to Ongoing Global Phase 3 Head and Neck Cancer Study
4:15pm
6-K
fr0sxtymthdwi61w9wd
11 Jan 24
Voting Rights and Shares Capital of the Company
5:50pm
6-K
d04i whgi9we7ntrfhml
26 Dec 23
Nanobiotix Partner LianBio Assigns Its Development and Commercialization Rights for NBTXR3 in China and Other Asian Markets
6:05am
6-K
yrspy5
13 Dec 23
Voting Rights and Shares Capital of the Company
4:15pm
6-K
fof hst8d
4 Dec 23
Current report (foreign)
4:32pm
6-K
6t5tdr09bnwlzxsf4et
13 Nov 23
NANOBIOTIX Provides Third Quarter 2023 Operational and Financial Update
4:15pm
6-K
4w6g770v1wrwauy6c7w
9 Nov 23
Current report (foreign)
4:15pm
6-K
wzb r0244hdcuh6q5u
9 Nov 23
Voting Rights and Shares Capital of the Company
9:00am
6-K
qp7 7bs29p
8 Nov 23
NANOBIOTIX Announces Closing of Global Offering
7:53am
6-K
375li98fnayuiuj
7 Nov 23
Current report (foreign)
7:02am
424B5
a5ks6cn
6 Nov 23
Prospectus supplement for primary offering
4:12pm
FWP
qd93gsls3n0k43xw5 zw
2 Nov 23
Free writing prospectus
4:36pm